What is the recommended dose of Augmentin (amoxicillin-clavulanate) for treating urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Augmentin for Urinary Tract Infections

For uncomplicated UTIs, Augmentin (amoxicillin-clavulanate) should be dosed at 500/125 mg orally every 8 hours for 5-7 days, or 875/125 mg orally every 12 hours for 5-7 days. 1

Dosing Recommendations Based on UTI Type

Uncomplicated UTIs

  • First-line option: 500/125 mg orally every 8 hours for 5-7 days
  • Alternative option: 875/125 mg orally every 12 hours for 5-7 days

Complicated UTIs

  • Standard dosing: 875/125 mg orally every 12 hours for 10-14 days 1
  • Alternative: 500/125 mg orally every 8 hours for 10-14 days 1

Pyelonephritis

  • Oral therapy: 875/125 mg orally every 12 hours for 14 days 2
  • Initial parenteral therapy may be needed for severe cases before transitioning to oral therapy

Clinical Evidence Supporting These Recommendations

The FDA label for Augmentin provides strong evidence for these dosing regimens based on clinical trials involving 1,191 patients with either lower respiratory tract infections or complicated UTIs. The trials demonstrated comparable efficacy between the 875/125 mg every 12 hours and 500/125 mg every 8 hours dosing regimens 1.

Importantly, the 875/125 mg every 12 hours regimen was associated with a statistically significant lower rate of severe diarrhea (1% vs 2%) compared to the 500/125 mg every 8 hours regimen 1.

Special Considerations

Renal Impairment

  • Creatinine clearance >30 mL/min: No dosage adjustment needed
  • Creatinine clearance 10-30 mL/min: 500/125 mg every 12 hours
  • Creatinine clearance <10 mL/min: 500/125 mg every 24 hours

Duration of Therapy

  • Uncomplicated UTIs: 5-7 days is typically sufficient 2
  • Complicated UTIs: 10-14 days is recommended 2, 1
  • Severe pyelonephritis: May require 14 days of therapy 2

Clinical Efficacy

Clinical trials have demonstrated bacteriological success rates of:

  • 81% at 2-4 days post-therapy
  • 52-58% at 5-9 days post-therapy
  • 52-55% at 2-4 weeks post-therapy 1

Earlier studies showed microbiological cure rates of 84% one week after treatment and 67% one month later in patients with recurrent UTIs treated with 250/125 mg every 8 hours for 7 days 3.

Potential Pitfalls and Caveats

  • Gastrointestinal side effects: Diarrhea is the most common adverse effect (14-15% of patients) 1
  • Resistance concerns: Consider local resistance patterns before prescribing
  • Drug interactions: Monitor patients on anticoagulants as Augmentin may increase INR
  • Allergic reactions: Contraindicated in patients with known hypersensitivity to penicillins

Alternative Options When Augmentin Cannot Be Used

For patients who cannot take Augmentin, the European Association of Urology recommends:

  • Fluoroquinolones (if local resistance <10%)
  • Trimethoprim-sulfamethoxazole (160/800 mg twice daily for 14 days)
  • Cephalosporins (e.g., cefpodoxime 200 mg twice daily for 10 days) 4

Remember that Augmentin is not considered first-line therapy for uncomplicated cystitis according to current guidelines, but it remains a valuable option for complicated UTIs or when first-line agents cannot be used due to resistance or contraindications.

References

Guideline

Treatment of Enterococcal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.